‘There are many non-hallucinogenic analogues of LSD, but the fundamental difference is that all of those compounds are very ...

In a mouse model of chronic stress ... “No one really wants to give a hallucinogenic molecule like LSD to a patient with schizophrenia,” said Olson, who is co-founder and chief innovation ...

In a model where mice had been stressed to the point of losing ... “No one really wants to give a hallucinogenic molecule like LSD to a patient with schizophrenia. The development of JRT emphasizes ...

To see whether STING is involved in other LSDs, Dr. Yan's team at UTSW worked with a mouse model ... of Molecular Biology, and of Neurology, who is an expert on gene therapy for LSD patients.

Their study, published in Molecular Cell, helps explain critical ... Dr. Yan's team at UTSW worked with a mouse model of an LSD called Krabbe disease with the same mutation found in human disease.

So in 2017 we ran an article on organoids by a researcher named Jürgen Knoblich from the Institute of Molecular Biotechnology ... to develop an internal mental model of reality.

While others have made analogs of LSD, the resulting molecules have substantially different molecular skeletons or weights than LSD has. Olson wanted to make an analog that would simply swap the p ...